LunaRx review
Bundled, bilingual, no standalone
A bilingual practice that names its secretagogue blend clearly — and will only sell it attached to a GLP-1 prescription.
Our verdict
LunaRx has a coherent clinical idea and states it well: protect lean mass through a caloric deficit with a named CJC-1295/ipamorelin blend, then taper off the GLP-1 on a structured schedule rather than staying on it indefinitely. Naming the peptide, explaining why it is in the stack, and building an off-ramp are all better than this board's norm, and the English/Spanish care is genuinely uncommon. But every purchasable product is a GLP-1 stack. If you came for a peptide on its own, LunaRx does not sell one, and the "from $199/mo" headline is the semaglutide tier, not a peptide price.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- Peptide telehealth
- Access
- NAD⁺ injection sits inside the tirzepatide stack; no standalone NAD⁺ product and no NAD⁺ price published
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake
- Availability
- Not published; limited to states where LunaRx is licensed
- Updated
- July 2026
Popular alternative
Oak Longevity
Low-cost sermorelin within a broader longevity stack
Check Oak Longevity availability →What it is
LunaRx (LunaRx LLC of Austin, Texas) is a bilingual English/Spanish telehealth practice built around what it calls metabolic recomposition. It sells three stacks: a Foundation tier pairing compounded semaglutide with a CJC-1295/ipamorelin blend for muscle preservation; a Premier tier pairing compounded tirzepatide with an NAD⁺ injection; and an Elite tier that runs full tirzepatide plus CJC-1295/ipamorelin for four months, then a systematic two-month taper with GI-reset peptide support and high-volume B12. Prescribing runs through CareNexus Clinic PC, an independent medical group named in its terms. Its only individual treatment pages are semaglutide, tirzepatide and a GLP-1 microdose.
How it works
Asynchronous and physician-directed, with monthly check-ins and dose titration described as part of every stack, plus discreet direct-to-door shipping and 503A compounding stated as requiring no reconstitution. The founder is named — Anamaria Galvan, RN — as is the prescribing medical group, and eligibility is free: the site states $0 is charged if you are not approved. Clinical support hours are published, in both English and Spanish, across phone, email and secure messaging. The structural thing to understand is that the peptides are stack components rather than products. The nav item labelled longevity and composition points back to the stack section, and no treatment page exists for CJC-1295, ipamorelin or NAD⁺ individually, so the peptide arrives as part of a GLP-1 prescription or not at all. Disclosure gaps are real: no LegitScript or PCAB verification anywhere, no named compounding pharmacy, and a contradiction on geography — treatment pages say telehealth nationwide while the terms restrict service to states where LunaRx is licensed, with no list published. Refunds are limited: orders can be cancelled within 24 hours and nothing is refunded once medication is dispensed.
Pricing transparency
One figure is published: from $199/mo for the entry Foundation stack, and the site states plainly that pricing is confirmed after your provider review. That $199 buys compounded semaglutide plus the CJC-1295/ipamorelin blend together, so it is not a peptide price and is not treated as one here. Tirzepatide-based Premier and Elite tiers cost more and no number for either appears anywhere. Before starting, ask three things: what the stack costs at your tier, whether the peptide component is separable or priced at all on its own, and what happens to your monthly cost during the taper months, since the Elite blueprint changes its composition halfway through. The site says flat-rate with no hidden fees, and the included components — medication, monthly physician check-in, titration and shipping — are listed clearly, which makes the bundle easier to assess once you have a number for it.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. LunaRx discloses the compounded status and says its preparations are 503A compounded in the USA by partner compounding pharmacies, but it does not name them, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the CJC-1295/ipamorelin blend is a growth-hormone secretagogue combination — CJC-1295 a GHRH analogue that raises the baseline of growth hormone release, ipamorelin a selective ghrelin-receptor agonist that adds a pulse — so it works through your own pituitary rather than supplying growth hormone. The mechanism is real and well described. Human outcome data for the blend, and specifically for the lean-mass-preservation claim made for it during a GLP-1 caloric deficit, is thin; muscle loss on GLP-1 therapy is a genuine and well-documented problem, but the evidence that a secretagogue blend fixes it is not there yet. Injected NAD⁺ has no controlled human outcome trials at all; the oral precursors NR and NMN are the forms with human data and what they raise is a blood level. Individual results vary.
Pros and watch-outs
What we like
- Names the secretagogue blend — CJC-1295/ipamorelin — and states why it is in the stack
- Operating entity, founder and prescribing medical group all named: LunaRx LLC, Anamaria Galvan RN, CareNexus Clinic PC
- Structured off-ramp taper with GI-reset support instead of an indefinite prescription
- Bilingual English and Spanish care across intake, messaging and consults, with published clinical hours
- $0 charged if you are not approved, and cancel-anytime terms on the subscription
Watch-outs
- No standalone peptide product — CJC-1295/ipamorelin and NAD⁺ are only sold inside a GLP-1 stack
- The "from $199/mo" headline is the semaglutide stack price, not a peptide price; tirzepatide tiers are unpriced
- No LegitScript or PCAB verification displayed anywhere
- Compounding pharmacy not named
- Treatment pages claim nationwide telehealth while the terms limit service to licensed states, with no list published
Best for
People already committing to a compounded GLP-1 who want a named secretagogue blend and a planned exit built into the same program, in English or Spanish.
Who should look elsewhere
Anyone who wants a peptide on its own, anyone who needs certification or a named pharmacy, or anyone who needs to confirm state coverage before paying.
The evidence behind what LunaRx prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- Ipamorelin & CJC-1295: the honest evidence on GH secretagogue peptides
They reliably raise growth hormone — that part is real. The muscle, fat-loss and anti-aging claims are not supported by human outcome data. A straight read.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
How LunaRx compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Meto
NAD⁺ buyers who want bloodwork behind the prescription and the price published in advance
See Meto → - Maves
NAD⁺ at a published all-in monthly price across all 50 states
See Maves → - Lumora
A certified 50-state NAD⁺ program if you will complete an assessment before seeing anything
See Lumora →
Peptides & longevity · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of LunaRx’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Can I buy the peptide without the GLP-1?
- Not from what LunaRx publishes. Its only treatment pages are semaglutide, tirzepatide and a GLP-1 microdose, and the CJC-1295/ipamorelin blend and NAD⁺ injection appear only as components inside the three stacks. If you want a standalone secretagogue, ask directly before starting.
- What does the $199 actually cover?
- The entry Foundation stack — compounded semaglutide plus the CJC-1295/ipamorelin blend, a monthly physician check-in, dose titration as needed and discreet shipping. It is a stack price, not a peptide price. The site states pricing is confirmed after your provider review, and the tirzepatide-based tiers cost more without a published figure.
- Does a secretagogue blend really protect muscle on a GLP-1?
- Muscle loss during GLP-1 therapy is a real, well-documented problem, and CJC-1295 and ipamorelin do act on the growth-hormone axis through your own pituitary. What is missing is human outcome data showing the blend preserves lean mass in people losing weight on a GLP-1. Treat it as a plausible mechanism rather than a proven result, and weigh resistance training and protein intake alongside it.
- Is LunaRx available in my state?
- It does not say. Its treatment pages describe nationwide telehealth, but the terms limit service to individuals located in states where LunaRx LLC operates, and no list is published — a contradiction worth resolving before you pay. Note also that orders can only be cancelled within 24 hours and nothing is refunded once medication is dispensed.